POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES Drug Patent Profile
When do Polyethylene Glycol 3350 And Electrolytes patents expire, and when can generic versions of Polyethylene Glycol 3350 And Electrolytes launch?
Polyethylene Glycol 3350 And Electrolytes is a drug marketed by Paddock Llc and Strides Pharma and is included in two NDAs.
The generic ingredient in POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There is one drug master file entry for this compound. Eight suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES?
- What are the global sales for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES?
- What is Average Wholesale Price for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES?
Summary for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 14 |
| DailyMed Link: | POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES at DailyMed |
Recent Clinical Trials for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| General Hospital of Shenyang Military Region | NA |
| Hitit University | PHASE4 |
| Institute of Medical Sciences and SUM Hospital | PHASE4 |
See all POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES clinical trials
Pharmacology for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES
| Drug Class | Osmotic Laxative Potassium Salt |
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption Stimulation Large Intestine Fluid/Electrolyte Secretion |
US Patents and Regulatory Information for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Paddock Llc | POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES | polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous | FOR SOLUTION;ORAL | 090712-001 | Feb 25, 2010 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Strides Pharma | POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES | polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous | FOR SOLUTION;ORAL | 204558-001 | Dec 21, 2018 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
